Registry-listed formulations

Dopamine hydrochloride · chembl:CHEMBL1557

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

2 source entries across 2 studies. This list may not include all unresolved or historical entries.

  • Dopamine hydrochlorideRegistry intervention

    Linked study entry; product equivalence not established

    View study and source
  • Dopamin Fresenius 50 mg/5 ml, Konzentrat zur Herstellung einer InfusionslösungRegistry product

    Molecular identity unconfirmed

    Formulation reported by source: SOLUTION FOR INFUSION

    Named ingredient; exact form unconfirmed. This mention does not add to the molecule trial count.

    View study and source

Success Metrics

Completion Rate
0%(0/1)
Active Trials
0(0%)
Terminated
1(100%)

Phase Distribution

Phase 3
1
100%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution1 total trials
Phase 3Large-scale testing
1(100.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

1

all time

Status Distribution
Terminated(1)

Detailed Status

Terminated1

Development Timeline

Analytics

Development Status

Total Trials
1
Active
0
Success Rate
0.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (100.0%)

Trials by Status

terminated1100%

Recent Activity

0 active trials
Showing 1 of 1
terminatedphase_3

Management of Hypotension In the Preterm Infant

NCT01482559

Clinical Trials (1)

Showing 1 of 1 trials
NCT01482559Phase 3

Management of Hypotension In the Preterm Infant

Terminated

All 1 trials loaded

Drug Details

Intervention Type
Drug
Molecule Type
Small molecule
Total Trials
1

External References

ChEMBL
CHEMBL1557

Names & Codes

Research Codes

ASL-279NSC-169105